Skip to content

Ayurvedic management for gout

Assessment of patoladi kwatha in vaatarakta in comparison with febuxostat with special reference to gout - A randomized controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/07/019972
Enrollment
60
Registered
2019-07-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

Intervention1: Patoladi kwatha: Contents and preparation of patoladi kwatha - Patol, katuka, shatavari,amalaki, haritaki, bibhitaki, guduchi- each 6.8 gm All the above ingredients will be grind finely

Sponsors

Dr Rukhsar Sheikh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either gender Patients with age 18 to 70 years Serum uric acid level >7 mg / dl for men and > 6 mg / dl for women Chronic cases of gout ( more than 1 year )

Exclusion criteria

Exclusion criteria: Immunocompromised patients or patients on immunosuppressive drugs Patients suffering from life threatening diseases Pregnant women and lactating mother Patients with k/c/o hypersensitivity of any drug Patients suffering from chronic kidney diseases or end stage renal diseases and requiring dialysis Patients taking diuretics, aspirin, ethambutol, pyrazinamide, cyclosporine, cytotoxic drug

Design outcomes

Primary

MeasureTime frame
Patoladi kwatha more effective in management of vaatarakta than febuxostatTimepoint: once in a month for three months

Secondary

MeasureTime frame
The effect of patoladi kwatha will be less effective as compared to febuxostat on vaataraktaTimepoint: once in a month for three months

Countries

India

Contacts

Public ContactDr Mahesh Pandey

Y.M.T. Ayurvedic medical college

drpandeymahesh@gmail.com9820006082

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026